Study of ISU104, Targeting ERBB3 in Patients With Advanced Solid Tumors

Condition:   Solid Tumor
Intervention:   Biological: ISU104
Sponsor:   ISU Abxis Co., Ltd.
Recruiting

https://ift.tt/2JJwHRa